ATAI Life Sciences (NASDAQ: ATAI)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ATAI Life Sciences (NASDAQ: ATAI) through any online brokerage.
There are no as such competitors for ATAI Life Sciences.
The latest price target for ATAI Life Sciences (NASDAQ: ATAI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ATAI to fall to within 12 months (a possible -12.66% downside). 50 analyst firms have reported ratings in the last year.
The stock price for ATAI Life Sciences (NASDAQ: ATAI) is $4.58 last updated August 12, 2022, 8:00 PM UTC.
The next ATAI Life Sciences (ATAI) dividend date is projected to be Thursday, September 1, 2022.
ATAI Life Sciences’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for ATAI Life Sciences.
ATAI Life Sciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.